Myelodysplastic syndromes;Les syndromes myelodysplasiques

Annales de Biologie Clinique

Volumn 58, Issue 4, 2000, Pages 405-416

  Garandeau, C ^a   Pautas, E ^a   Andreux, M H ^a   Andreux, J P ^a   Gaussem, P ^a   Siguret, V ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

Cytopenia; Myelodysplastic syndrome; Refractory anaemia; Sideroblasts

Indexed keywords

CHRONIC MYELOMONOCYTIC LEUKEMIA; CLASSIFICATION; CYANOCOBALAMIN DEFICIENCY; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FOLIC ACID DEFICIENCY; HEMATOPOIETIC STEM CELL; HUMAN; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFRACTORY ANEMIA; REVIEW; SIDEROBLASTIC ANEMIA;

DIAGNOSIS, DIFFERENTIAL; HEMATOPOIETIC STEM CELLS; HUMANS; MYELODYSPLASTIC SYNDROMES;

EID: 0034220740     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Proposals for the classification of the myelodysplastic syndromes
2. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes
3. Hypocellular myelodysplastic syndromes (MDS): New proposals
4. Myelofibrosis in primary myelodysplastic syndromes: A retrospective study of 352 patients
5. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes
6. Increasing incidence of myelodysplastic syndromes: A real or fictious?
7. Establishing the incidence of myelodysplastic syndrome
8. Syndromes myelodysplasiques de l'enfant
9. Increasing prevalence of the myelodysplastic syndromes: An internationnal Delphi study
10. Facteurs etiologiques des syndromes myelodysplasiques
11. Myelodysplastic syndromes
12. Risk of acute myelogenous leukemia and myelodysplasia following cancer treatment
13. Myelodysplastic syndromes
14. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion: An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations
15. A hypothesis for the pathogenesis of myelodysplastic syndromes: Implications for therapies
16. The myelodysplastic syndromes
17. Immunological abnormalities in myelodysplastic syndromes
18. Associations entre maladies systemiques et syndromes myelodysplasiques
19. Myelodysplastic syndromes and relapsing polychondritis: Further evidence
20. Myelodysplastic syndromes: Clinical features
21. Syndromes myelodysplasiques et deletion 5q
22. Cytogenetics of myelodysplastic syndromes
23. Cytogenetic analysis has strong independant pronostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report of 408 cases
24. International scoring system for evaluating prognosis in myelodysplastic syndromes
25. Prognostic classification in myelodysplastic syndromes
26. Myelodysplastic syndromes: A scoring system with prognostic significance
27. Strategie therapeutique dans les syndromes myelodysplasiques
28. Efficacy of erythropoietin in the myelodysplastic syndromes: A meta-analysis of 205 patients from 17 studies
29. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients
30. A review of 76 patients with myelodysplastic syndromes treated with danazol
31. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes
32. Treatment with growth factors in myelodysplastic syndromes
33. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes
34. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndromes
35. Chimiotherapie intensive dans les syndromes myelodysplasiques
36. Facteurs de croissance hemetopoietiques: Une place dans le traitement des syndromes myelodysplasiques